Skip to main content
SpringerLink
Log in

Efalizumab

Repigmentation (first report) in a patient with vitiligo: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Wakkee M, Assen YJ, Thio HB, Neumann HAM.Repigmentation of vitiligo during efalizumab. Journal of the American Academy of Dermatology 59 (Suppl. 1): 57-58, No. 2, Aug 2008 - Netherlands

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Efalizumab. React. Wkly. 1212, 15 (2008). https://doi.org/10.2165/00128415-200812120-00046

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812120-00046

Keywords

Search

Navigation